Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors
“The addition of
“I look forward to working with the Clearside team to leverage the Company’s proprietary suprachoroidal space injection platform,” said
Investor and Media Contacts:
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/27843a49-a1c9-4e2f-a571-ff96a1a56ae3
Source: Clearside Biomedical, Inc.